NOTCH1 and acute lymphoblastic leukemia: In aggressive NOTCH1-mutated human PDX-T-ALL models, the l-asparaginase-containing VXL regimen, in combination with IACS-010759, led to the metabolic and transcriptional collapse of T-ALL cells resulting in a significant reduction in tumor burden and prolonged survival.